Tomokazu Sazuka   Naoki Nihei   Kazuyoshi Nakamura   Shinichi Sakamoto   Satoshi Fukasawa   Atsushi Komaru   Takeshi Ueda   Tatsuo Igarashi   Tomohiko Ichikawa   
Korean Journal of Urology 56(3) 205-211 2015年 [査読有り]
Purpose: Single-agent interferon (IFN) is no longer regarded as a standard option for first-line systemic treatment of metastatic renal cell carcinoma (RCC) in Western countries. However, some patients with favorable-risk RCC may still achieve com...